GTSE1 and nonpapillary renal cell carcinoma: The results demonstrated that GTSE1 was positively correlated with HRD in ccRCC and that the overexpression of GTSE1 could increase cell viability and decrease the apoptosis rate in ccRCC cells treated with cisplatin, while the knockdown of GTSE1 could decrease cell viability and increase the apoptosis rate in ccRCC cells treated with cisplatin.